tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nanobiotix Secures $71 Million Financing and Advances Cancer Treatment Programs
PremiumCompany AnnouncementsNanobiotix Secures $71 Million Financing and Advances Cancer Treatment Programs
2M ago
Nanobiotix Advances Curadigm Nanoprimer Platform with New Patents and Preclinical Data
Premium
Company Announcements
Nanobiotix Advances Curadigm Nanoprimer Platform with New Patents and Preclinical Data
3M ago
Nanobiotix Announces Updated Voting Rights and Share Capital
Premium
Company Announcements
Nanobiotix Announces Updated Voting Rights and Share Capital
3M ago
Nanobiotix Secures $71 Million Royalty Agreement with HealthCare Royalty
PremiumCompany AnnouncementsNanobiotix Secures $71 Million Royalty Agreement with HealthCare Royalty
3M ago
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
Premium
The Fly
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
3M ago
Nanobiotix Transfers Phase 3 Trial Control to J&J, Updates on NBTXR3 Program
Premium
Company Announcements
Nanobiotix Transfers Phase 3 Trial Control to J&J, Updates on NBTXR3 Program
3M ago
Nanobiotix Reports Promising Phase 1 Results for Esophageal Cancer Treatment
PremiumCompany AnnouncementsNanobiotix Reports Promising Phase 1 Results for Esophageal Cancer Treatment
4M ago
Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
Premium
The Fly
Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
4M ago
Nanobiotix Reports Half-Year 2025 Financial Results and Strategic Progress
Premium
Company Announcements
Nanobiotix Reports Half-Year 2025 Financial Results and Strategic Progress
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100